Skip to main content

Advertisement

SpringerLink
Log in

Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Osteoporosis is associated with the pathogenesis of urinary stone formation. Urinary stones are similar to bone diseases such as osteoporosis and bone metabolism in terms of pathogenesis. Bisphosphonates are potent inhibitors of bone resorption, and are used in the management of bone disease. Furthermore, bisphosphonates have a strong affinity for calcium, and a reported inhibitory effect on calcium oxalate crystallization in vitro. Thus, bisphosphonates might also inhibit urinary stone formation. Madin-Darby canine kidney (MDCK) cells form calcium phosphate microliths at the basolateral side in vitro. We investigated the inhibitory effects of new generation bisphosphonates (alendronate and incadronate) on calcium phosphate microlith formation and on the expression of osteopontin, which is an important urinary stone matrix. MDCK cells formed two types of colonies in three-dimensional soft agar culture; dark colonies containing calcium phosphate microliths and clear colonies free from microliths. We applied purified alendronate and incadronate at concentrations of 10−11, 10−9, 10−7 and 10−5 M to MDCK cells cultured in three-dimensional soft agar and investigated the efficiency of colony formation and the dark colony ratio (number of dark colonies relative to the total number of colonies). The administration of 10−9 and 10−7 M alendronate decreased the dark colony ratio compared with controls, whereas incadronate did not significantly alter this colony ratio compared with controls. The expression of osteopontin in cultured cells was inhibited by the 10−7 M alendronate administration. The present findings show that alendronate inhibits calcium stone formation, suggesting that it is effective in the prevention of urolithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Azuma Y, Sato H, Oue Y, Okabe K, Ohta T, Tsuchimoto M, Kiyoki M (1995) Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models. Bone 16: 235

    Article  CAS  PubMed  Google Scholar 

  2. Bone HG, Zerwekh JE, Britton F, Pak CYC (1979) Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J Urol 121: 568

    PubMed  Google Scholar 

  3. Boyce WH (1968) Organic matrix of human urinary cincretions. Am J Med 45: 673

    CAS  PubMed  Google Scholar 

  4. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS (1999) Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234

    Article  CAS  PubMed  Google Scholar 

  5. Charles RG, Water LH, Thomas FS (1966) Characterization of an established line of canine kidney cells. Esta Canine Kidney Cell 122: 931

    Google Scholar 

  6. Ebisuno S, Kohjimoto Y, Nishikawa Toru, Nishihata M, Inagaki T, Komura T, Ohkawa T (1998) Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells. Int J Urol 5: 582

    CAS  PubMed  Google Scholar 

  7. Fleisch H (1987) Bisphosphonate: history and experimental basis. Bone 8: S23

    CAS  PubMed  Google Scholar 

  8. Fleisch H (1991) Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 42: 919

    Google Scholar 

  9. Ito M, Chokki M, Ogino Y, Satomi Y, Azuma Y, Ohta T, Kiyoki M (1998) Comparison of cytotoxic effects of bisphosophonates in vitro and in vivo. Calcif Tissue Int 63: 143

    Article  CAS  PubMed  Google Scholar 

  10. Kageyama S, Ohtawara Y, Fujita K, Watanabe T, Ushiyama T, Suzuki K, Naito Y, Kawabe K (1996) Microlith formation in vitro by Madin-Darby canine kidney (MDCK) cells. Int J Urol 3: 23

    CAS  PubMed  Google Scholar 

  11. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168: 1173

    Article  CAS  PubMed  Google Scholar 

  12. Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Shinohara H, Kurita T (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184: 859

    CAS  PubMed  Google Scholar 

  13. Kohri K, Nomura S, Kitayama Y, Kitayama Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umehara T, Suzuki Y, Shiohara H, Kurita T (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268: 15180

    CAS  PubMed  Google Scholar 

  14. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RWJr, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333: 14378

    Article  Google Scholar 

  15. Mallory FB (1961) Pathological technique. Hafner, New York

  16. Naito Y, Ohtawara S, Kageyama S, Nakano M, Ichiyama A, Fujita M, Suzuki K, Kawabe K, Kino I (1997) Morphological analysis of renal cell culture models of calcium phosphate stone formation. Urol Res 27: 194

    Google Scholar 

  17. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BLH (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization, J Cell Biol 106: 441

    Google Scholar 

  18. Oberleithaler H, Steighner W, Silbernabl S, Vogel U, Gestraunthler G, Pfaller W (1990) Madin Darby canine kidney cells. Aldosterone stimulates an apical H+/K+ pump. Pflugers Arch 416: 540

    PubMed  Google Scholar 

  19. Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gry-Asp cell binding sequence. Proc Natl Acad Sci U S A 83: 8819

    CAS  PubMed  Google Scholar 

  20. Pak CYC (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18: 624

    CAS  PubMed  Google Scholar 

  21. Robertson WG, Peacock M, Marshall RW, Knowles F (1974) The effect of ethane 1-hydroxy-1, bisphosphonate(EHDP) on calcium oxalate crystalluria in recent renal stone formers. Clin Sci Mol Med 47: 13

    CAS  PubMed  Google Scholar 

  22. Ruml LA, Dubois SK, Roberts ML, Pak CY (1995) Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate. J Bone Miner Res 10: 655

    CAS  PubMed  Google Scholar 

  23. Sakakura T, Fujita K, Yasui T, Sasaki S, Mabuchi Y, Iguchi M, Kohri K (1999) Calcium phosphate stones produced by Madin-Darby canine kidney (MDCK) cells inoculated in nude mice. Urol Res 27: 200

    Article  CAS  PubMed  Google Scholar 

  24. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H (1995) β-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15: 2003

    CAS  Google Scholar 

  25. Uribarri J, Man S, Carroll JH (1989) The first kidney stone. Ann Intern Med 111: 1006

    CAS  PubMed  Google Scholar 

  26. Yasui T, Fujita K, Sasaki S, Iguchi M, Hirota S, Nomura S, Azuma Y, Ohta T, Kohri K (1998) Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney. Urol Res 26: 355

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported, in part, by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (no. 13770889 and no. 12307032).

Author information

Authors and Affiliations

  1. Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

    Hiroya Senzaki, Takahiro Yasui, Atsushi Okada, Yasunori Ito, Keiichi Tozawa & Kenjiro Kohri

Authors
  1. Hiroya Senzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takahiro Yasui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsushi Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasunori Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiichi Tozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenjiro Kohri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takahiro Yasui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senzaki, H., Yasui, T., Okada, A. et al. Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model. Urol Res 32, 223–228 (2004). https://doi.org/10.1007/s00240-004-0409-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-004-0409-7

Keywords

Search

Navigation